DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Gordon AN, Fleagle JT, Guthrie D. et al.
Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicn versus topotecan.
J Clin Oncol 2001; 19: 3312-3322
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.